Naini Nader J
Insider CIK 1344203 · GKOS 10% owner · COLL 10% owner · ANAB 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ANAB ANAPTYSBIO INC | J Other | 2018-05-11 | 2018-05-15 | 1,372,000 | — | $0 | 973,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | J Other | 2018-05-11 | 2018-05-15 | 1,372,000 | — | $0 | 973,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise deriv | 2017-02-02 | 2017-02-06 | 117,235 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise deriv | 2017-02-02 | 2017-02-06 | 117,235 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise | 2017-02-02 | 2017-02-06 | 117,235 | $4.55 | $533.4K | 2,345,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | X Exercise | 2017-02-02 | 2017-02-06 | 117,235 | $4.55 | $533.4K | 2,345,612 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion deriv | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 0 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 311,291 | $15.00 | $4.67M | 311,291 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 209,095 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 195,751 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 604,055 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 1,428,571 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 88,709 | $15.00 | $1.33M | 88,709 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 733,740 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 733,740 | — | $0 | 733,740 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 195,751 | — | $0 | 195,751 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 209,095 | — | $0 | 209,095 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 311,291 | $15.00 | $4.67M | 311,291 | SEC↗ |
| ANAB ANAPTYSBIO INC | P Buy | 2017-01-31 | 2017-01-31 | 88,709 | $15.00 | $1.33M | 88,709 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 1,428,571 | — | $0 | 1,428,571 | SEC↗ |
| ANAB ANAPTYSBIO INC | C Conversion | 2017-01-31 | 2017-01-31 | 604,055 | — | $0 | 604,055 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 151,653 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 253,390 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 1,523,809 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion deriv | 2015-06-30 | 2015-06-30 | 674,510 | — | $0 | 0 | SEC↗ |
| GKOS GLAUKOS Corp | C Conversion | 2015-06-30 | 2015-06-30 | 2,603,362 | — | $0 | 2,603,362 | SEC↗ |
| GKOS GLAUKOS Corp | X Exercise deriv | 2015-06-26 | 2015-06-30 | 24,705 | $7.65 | $189.0K | 674,510 | SEC↗ |
| GKOS GLAUKOS Corp | X Exercise deriv | 2015-06-26 | 2015-06-30 | 24,705 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 2,705,585 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 4,019,183 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 3,676,078 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion deriv | 2015-05-12 | 2015-05-14 | 1,533,399 | — | $0 | 0 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 582,490 | — | $0 | 582,490 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | P Buy | 2015-05-12 | 2015-05-14 | 150,000 | $12.00 | $1.80M | 1,887,332 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 540,498 | — | $0 | 1,737,332 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 392,113 | — | $0 | 1,196,834 | SEC↗ |
| COLL COLLEGIUM PHARMACEUTICAL, | C Conversion | 2015-05-12 | 2015-05-14 | 222,231 | — | $0 | 804,721 | SEC↗ |